Abstract
(Abstracted from Am J Obstet Gynecol 2020;222(5):437-450) Low-dose aspirin has been shown to decrease the rate of preterm preeclampsia in women identified as high risk. The ASPRE (Combined Multimarker Screening and Randomized Patient Treatment with Aspirin for Evidence-Based Preeclampsia Prevention) trial found that high-risk women who received aspirin versus placebo saw a substantially reduced rate of preterm preeclampsia.
| Original language | English |
|---|---|
| Pages (from-to) | 581-582 |
| Number of pages | 2 |
| Journal | Obstetrical and Gynecological Survey |
| Volume | 75 |
| Issue number | 10 |
| DOIs |
|
| Publication status | Published - 1 Oct 2020 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'Does Low-Dose Aspirin Initiated before 11 Weeks' Gestation Reduce the Rate of Preeclampsia?'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver